Levoxyl (levothyroxine sodium) tablets, USP, 137 mcg, packaged in a) 100-count b Supply Disruption — King Legacy, a wholly owned s
Levoxyl (levothyroxine sodium) tablets, USP, 137 mcg, packaged in a) 100-count b Supply Disruption — King Legacy, a wholly owned s is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Levoxyl (levothyroxine sodium) tablets, USP, 137 mcg, packaged in a) 100-count b; Manufacturer: King
| Drug name | Levoxyl (levothyroxine sodium) tablets, USP, 137 mcg, packaged in a) 100-count b |
|---|---|
| Manufacturer | King Legacy, a wholly owned subsidiary of Pfizer |
| Recall/Disruption reason | Subpotent Drug: The products were below specification for potency at the expiry stability point. |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-428-2013 |
| Initiation date | 20130430 |
| Quantity affected | 77,272 bottles |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →